对人类化学诱导肝脏原始体中可能发生的端粒酶逆转录酶促进子突变的调查
Baglan Askeyev1, Akihiko Soyama1, Daisuke Miyamoto1
1Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
概括
在人类化学诱导肝脏原始体 (hCLiPs) 中,没有特洛马酶逆转录酶 (TERT) 促进子突变. 这表明基因组稳定性,支持它们在临床应用中的使用.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 干细胞生物学 干细胞生物学
- 基因组稳定性的研究.
背景情况:
- 端粒酶逆转录酶 (TERT) 促进子突变在肝细胞癌 (HCC) 中很常见.
- 人类化学诱导的肝脏前体 (hCLiPs) 是肝脏再生的潜在细胞来源.
- 评估hCLiP的基因组变化对于它们的临床转化至关重要.
研究的目的:
- 为了研究hCLiPs中的TERT促进子突变.
- 评估这些突变与致癌的关联.
- 为潜在的临床应用确定hCLiPs的基因组稳定性.
主要方法:
- 使用滴滴数字PCR分析TERT促进子突变 (C228T和C250T).
- 这些样本包括HCC (n=20),肝硬化 (LC) (n=19) 和hCLiPs (n=5).
- 基因组DNA从固定在甲,嵌入在中的组织中提取出来.
主要成果:
- 在hCLiP或LC样本中没有检测到TERT促进子突变.
- 在20个HCC样本中的11个 (55%) 中发现了TERT促进子C228T突变.
- 在任何分析的样本中都没有检测到C250T突变.
结论:
- hCLiPs没有TERT促进子突变,这表明基因组稳定性.
- 这些发现支持hCLiP的安全性和潜在的临床适用性.
- TERT促进子突变与HCC特别相关,而不是早期的祖先细胞或肝硬化.
相关概念视频
Telomeres and Telomerase
24.2K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
24.2K
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K


